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ABSTRACT
Background: Candida albicans (C. albicans) are dimorphic fungi in oral cavity, considered not only as normal flora, but also as 
pathogens. C. albicans have an ability to grow biofilm, which has a thick layer of outer skin structure, called as extracellular matrix. 
Jengkol leaves (Pithecellobium jiringa) contain alkaloids, flavonoids, terpenoids, and lectins, which have an ability as antifungal 
agent Purpose: This study aimed to analyze the optimum dose of jengkol leaf extract as antibiofilm against C. albicans biofilms. 
Method: C. albicans were cultured on yeast peptone dextrosa (YPD) media in 96-well microtiter plate flat bottom plates. There were 
one control group (without treatment) and three treatment groups. The first treatment group was given jengkol leaf extract at a dose 
of 100 mg/ ml. The second treatment group was given jengkol leaf extract at a dose of 200 mg/ ml. And, the third treatment group was 
given jengkol leaf extract at a dose of 400 mg/ ml. Semi quantitative method was applied to determine C. albicans biofilmsis using 
Crystal Violet staining technique. The absorbance of the cells then was calculated using a spectrophotometer with a wavelength of 
570 nm. Result: The mean value of optical density in the control group was 1.23. The mean value of optical density in the treatment 
group with a dose of 100 mg/ ml was 0.2. Meanwhile, the mean value of optical density in the treatment group with a dose of 200 mg/ 
ml was 0.2, and 0.21 in the treatment group with a dose of 400 mg/ ml. The results also showed that there were significant differences 
between the control group and all of the treatment groups (p<0.05), but there was no significant difference between the treatment 
groups (p>0.05). Conclusion: The optimum dose of jengkol leaf extract used as antibiofilm against C. albicans biofilms is 100 mg / 
ml with an inhibitory percentage of 83.7%.
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INTRODUCTION
Candida albicans (C. albicans) are dimorphic fungi in 
oral cavity, considered not only as normal flora, but also as 
pathogens. If the growth of C. albicans in the oral cavity is 
excessive, it can trigger certain diseases.1 Those diseases 
are usually such fungal infections that are known as oral 
candidiasis.2 According to a research conducted by Parman, 
the prevalence of fungal infections caused by C. albicans 
is high, ie 55 cases out of 100 patients. Similarly, based 
on data from the Directorate General of Disease Control 
and Environmental Health of the Ministry of Health of the 
Republic of Indonesia, there were 21,591 cases in 2010, 
21,031 cases in 2011, and 21,511 cases in 2012 related 
to Human immunodefisiency Virus (HIV) in Indonesia, 
10,689 of which are also classified as oral candidiasis 
caused by C. albicans.3,4
Candida is a type of fungus that has a high prevalence 
in the formation of biofilms, particularly C. albicans. 
C. albicans biofilms have the outermost layer structure, 
called as extracellular matrix. Extracellular matrix is 
formed by polysaccharide that serves to maintain stability 
of C. albicans while growing and developing.5 Oral 
candidiasis, can be classified based on clinical symptoms. 
Classic type commonly occurs is pseudomembranous 
candidiasis. Pseudomembranous candidiasis patients 
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have certain clinical symptoms, such as disturbing pain 
in the area of  oral infections. Bleeding then can occurs 
when pseudomembranous open. This disease even occurs 
potentially in patients who have been infected with HIV.2
Actually, there have been many choices for antifungal 
drugs on markets today, one of which widely used is azole 
class with certain side effects when consumed in long term. 
One of the side effects is in the form of hepatotoxicity. A 
research using experimental animals given fluconazole at 
a dose of 12.26 mg (the therapeutic dose in humans) per 
animal per day for 20 weeks, liver tumors even can emerge 
at week 10 after the administration.6
Jengkol (Pithecellobium jiringa) is a typical plant 
of Southeast Asia. Jengkol leaves contain flavonoids, 
tannins, alkaloids, steroids, glycosides, lectins, and steroids/
terpenoid.7,8 Alkaloids are able to impair mitochondrial 
function and consistency of the cell wall. Lectin has an 
ability to attach to mannose and hyphae. Lectins and 
flavonoids, furthermore, have an ability to disrupt cell 
interaction process.9,10 Terpenoid has an active role in 
inhibiting cell cycle process of C. albicans.11 Similarly, 
a research conducted by Bakar12 shows that the methanol 
extract of jengkol leaves (Pithecellobium jiringa) has 
antifungal power against C. albicans cells with minimum 
inhibitory concentration (MIC) of 100 mg/ ml.
Unfortunately, there have not many researches on the 
effects of antibiofilm derived from jengkol leaf extract, 
especially against C. albicans biofilms. Jengkol leaves have 
some natural chemical compounds considered to be able 
to work synergistically as antibiofilm. Thus, the results of 
this research can be considered as a scientific study for the 
development of traditional medicine expected to be applied 
as a candidate of antifungal drug selection.
MATERIALS AND METHOD
This research was an in vitro laboratory experimental 
research. C. albicans were cultured at the Laboratory 
of Microbiology in Faculty of Dentistry, Universitas 
Airlangga. Meanwhile, jengkol leaves were extracted at 
the Laboratory of Pharmacognosy in Faculty of Pharmacy, 
Universitas Airlangga. And, antibiofim test on C. albicans 
were conducted at the Laboratory of Microbiology in 
Faculty of Medicine, University of Brawijaya from June 
to July 2015.
Jengkol leaf extract at various concentrations were 
carried out in several stages. Jengkol leaves were taken 
from a cultivating garden in Ngantang, Malang. Jengkol 
leaves then were identified in the Technical Implementation 
Unit of Plant Conservation Center in Purwodadi (Unit 
Pelaksana Teknis Balai Konservasi Tumbuhan Kebun 
Raya Purwodadi Lembaga Ilmu Pengetahuan Indonesia) 
as a part of Indonesian Institute of Sciences in Pasuruan. 
Sampling of jengkol leaves was conducted with certain 
criteria, such as fresh, green, and planted at least for 5 
years. Jengkol leaves were separated from the stems and 
stalks. Those leaves then were dried up through wind, and 
crushed with a blender. 50 grams of jengkol leaf powder 
was put in an Erlenmeyer flask sized 250 ml, added with 
150 ml of methanol, and then macerated for 24 hours using 
a shaker. The results of this maceration were filtered with 
filter paper to obtain a filtrate. 
Jengkol leaf powder residue was added to the methanol 
and then re-macerated for 24 hours. Steps 4 and 5 were 
repeated until there was no color (clear) in thin layer 
chromatography (TLC) check. The solution derived from 
the filtration process was evaporated with rotary vacuum 
evaporator. The extract resulted was in the form of 
condensed extract weighed 5 grams. It was diluted at doses 
of 100 mg/ ml, 200 mg/ ml, and 400 mg/ ml. 
C. albicans used this research were cultured on yeast 
peptone dextrosa (YPD) media in a 96-well microtiter 
plate flat bottom plate. Ca. albicans biofilms then were 
made in several stages. 100 L suspension of C. albicans as 
the test concentration and sucrose 2% were added using a 
multichannel pipette to induce biofilm formation into 96-
well microtiter flat bottom plate. The entire microtiter plates 
were covered, wrapped with cling wrap, and then incubated 
for 24 hours at a temperature of 370 C. Multichannel 
pipette was used to rinse the plates repeatedly 3 times with 
sterile PBS (200 mL per well). Alternatively, automated 
microtitter plate washer can be used. During flushing and 
after the last rinsing, the plates were placed upside down 
and then closed with a paper towel to remove any residual 
PBS. In these circumstances, biofilms formed could be 
seen by inverted microscope. Biofilms then were ready to 
proceed to the antibiofilm testing process.
Afterwards, the samples were divided into four groups, 
consisted of one control group (no treatment) and three 
treatment groups. Those three treatment groups were given 
jengkol leaf extract at doses of 100 mg/ ml, 200 mg/ ml, and 
400 mg/ ml. Replication was performed in each treatment 
five times.
Jengkol leaf extract with doses of 100 mg/ ml, 200 mg/ 
ml, and 400 mg/ ml were applied to C. albicans biofilms 
that had been cultured in a 96-well microtiter flat bottom 
plate. By using multichannel pipette, jengkol leaf extract 
at a dose of 100 mg/ mL was added to column 1, a dose 
of 200 mg/ mL to column 2, and a dose of 400 mg/ mL to 
column 3. Column 4 as a control was not given the extract. 
The plates then were covered and incubated for 48 hours at 
a temperature of 370 C. After that, the plates were rinsed 
three times with sterile PBS (200 mL per well). Staining 
then was performed using crystal violet, and incubated for 
45 minutes. The whole wells were rinsed four times with 
sterile distilled water, and immediately given 200 mL of 
95% methanol. 100 μL of the methanol was taken using 
pipette to be replaced to a new well. Afterwards, absorbance 
of each well was measured using a spectrophotometer with 
a wavelength 570 nm.13
Data of the mean value of optical density then were 
derived from spectrophotometric readings. Optical density 
(OD) is a unit used to look turbidity of C. albicans biofilms 
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on microtiter plates. Turbidity illustrates the number of 
C. albicans biofilms attached to microtiter plates.14 The 
mean optical density value of each treatment group then 




(OD control at 570 nm - 
OD treatment at 570 nm) × 100
OD control at 570 nm
RESULTS
In this research, there were four groups, one control 
group (no treatment) and three treatment groups. Replication 
of each group was performed 6 times. Table 1 shows the 
values of optical density in each group, the control group 
and the treatment groups.
In Table 1, column with control information indicates 
the optical density value of the control group. Column with 
a caption 1 shows the optical density value of the jengkol 
leaf extract at a dose of 100 mg/ ml. Meanwhile, column 
with a caption 2 shows the optical density value of the 
jengkol leaf extract at a dose of 200 mg/ ml. Column with 
a caption 3 shows the optical density value of the jengkol 
leaf extract at a dose of 400 mg/ ml.
Table 2 shows the mean optical density values of the 
research groups. In the control group, the mean OD value 
was 1.23 with a standard deviation of 0.53. In the group with 
jengkol leaf extract at a dose of 100 mg/ ml, the mean OD 
value was 0.2 with a standard deviation of 0.01. Meanwhile, 
in the group with jengkol leaf extract at a dose of 200 mg/ ml 
OD, the mean OD value was 0.2 with a standard deviation 
of 0.02. In the group with jengkol leaf extract at a dose of 
400 mg/ ml, the mean OD value was 0.21 with a standard 
deviation of 0.03.
Normality test was performed using one-sample 
Kolmogorov-Smirnov test. P value  obtained for each 
sample was more than 0.05. It means that the data had 
normal distribution. Furthermore, after the homogeneity 
test (Levene test) was conducted, p value obtained was 
0.00 (p <0.05). It indicates that the data were homogeneous. 
Afterwards, to know the differences between the groups, 
Kruskal test was carried out. The significance value 
obtained was 0.003 (p<0.05). It means that there was a 
difference between the groups. Mann Whitney test then 
was performed to find significant differences between two 
groups. The results of Kruskal Wallis test also showed that 
there was significant differences between groups since the 
significance value obtained was less than 0.05 (0.003) as 
shown in Table 3.
Based on the results of Mann Whitney test, there was 
a significant difference between the control group and the 
treatment group with a dose of 100 mg/ ml (0.004). There 
was also a significant difference between the control group 
and the treatment group with a dose of 200 mg/ ml (0.004). 
Similarly, there was a significant difference between the 
control group and the treatment group with a dose of 400 
mg/ ml (0.004). 
However, there was no significant difference between 
the treatment group with a dose of 100 mg/ ml and the 
treatment group with a dose of 200 mg/ ml (0.371). 
Similarly, there was no significant difference between the 
treatment group with a dose of 100 mg/ ml and the treatment 
group with a dose of 400 mg/ ml (0.421). There was also 
no significant difference between the treatment group with 
Table 1.  OD values of Candida albicans biofilms after the administration of jengkol leaf extract (Pithecellobium jiringa) at a dose of 100 
mg/ ml, 200 mg/ ml, and 400 mg/ ml in the treatment groups as well as in the control group (without the administration)
Description




I II III IV V VI
Control Control 1.972 1.012 0.887 1.731 0.556 1.249
1 100 0.196 0.184 0.181 0.190 0.214 0.220
2 200 0.195 0.177 0.183 0.172 0.201 0.235
3 400 0.248 0.206 0.175 0.239 0.175 0.230
Table 2. The mean and standard deviation of OD values of Candida albicans biofilms after the administration of jengkol leaf extract 
(Pithecellobium jiringa) at a dose of 100 mg/ ml, 200 mg/ ml, and 400 mg/ ml in the treatment groups as well as in the 
control group (without the administration)
Data n X SD
Control 8 1.23 0.53
Jengkol leaf extract (Pithecellobium jiringa) (100 mg/ml) 8 0.2 0.01
Jengkol leaf extract (Pithecellobium jiringa) (200 mg/ml) 8 0.2 0.02
Jengkol leaf extract (Pithecellobium jiringa) (400 mg/ml) 8 0.21 0.03
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a dose of 200mg/ ml and the treatment group with a dose 
of 400 mg/ ml.
In addition, the diagram below (Figure 1) shows the 
inhibitory percentages of the whole groups against C. 
albicans biofilms. In the groups with doses of 100 mg/ ml 
and 200 mg/ ml, the inhibitory percentage for each was 
83.7%. Meanwhile, in the group with a dose of 400 mg/ 
ml, the inhibitory percentage was 81.3%. It means that 
there was a decrease of 2.4% in the inhibitory percentage 
of the treatment groups, from a dose of 400 mg/ ml to a 
dose of 200 mg/ ml.
DISCUSSION
In this study, jengkol leaf extract used was at doses of 
100 mg/ ml, 200 mg/ ml, and 400 mg/ ml. The determination 
of these doses was based on a preliminary study stating that 
jengkol leaf extract containing antifungal materials that has 
a minimum inhibition concentration (MIC) of 100 mg/ ml 
against C. albicans.12 In Table 2, the mean value of the 
optical density (OD) in the control group (untreated group) 
was 1.23, higher than the groups treated with doses of 100 
mg/ ml and 200 mg/ ml generating 0.2 for each, and a dose 
of 400 mg/ ml deriving 0.21. It means that the number of C. 
albicans biofilms in the treatment groups was fewer than 
in the control group (untreated group). It also indicates that 
there was no decline in the mean value of OD as the dose 
increased. There was an increase in the mean value of OD 
in the treatment group with a dose of 400 mg/ ml compared 
to the treatment group with a dose of 200 mg/ ml.
The increase in the mean value of OD at a dose of 
400 mg/ ml is likely to be caused by the resistance of C. 
albicans biofilms against jengkol leaves (Pithecellobium 
jiringa). The resistance of C. albicans biofilms to antifungal 
drugs is due to complex and multifactorial causes. Efflux 
pump is one of factors causing the resistance of C. albicans 
biofilms.15 Efflux pump is a form of fungal cell’s defense 
against agent/ antifungal drugs. Efflux pump occurs as a 
result of huge pressure from jengkol leaf extract at a dose 
of 400 mg/ ml, which affects osmolarity of the fungal 
cells. Efflux pump mechanism occurs by pumping out 
or secreting the antifungal agents through the fungal cell 
membrane using adenosine triphosphatase of binding 
cassette transporter (ATP-binding cassette transporter). 
As a result, the antifungal drugs that are already in the 
cells pumped out without making any contact with the 
drug targets.16
The inhibitory percentage of jengkol leaf extract against 
C. albicans biofilms (Figure 1) at a dose of 100 mg/ ml 
was 83.7%. Meanwhile, at a dose of 200 mg/ ml, the 
inhibitory percentage was 83.7%, and at a dose of 400 mg/ 
ml the inhibitory percentage was 81.3%. It indicates that 
jengkol leaf extract had inhibitory effects on C. albicans 
biofilm formation. Similarly, an initial research claims that 
jengkol leaf extract is antifungal against C. albicans cells.12 
Based on phytochemical examination in the laboratory of 
the Faculty of Pharmacy, Universitas Airlangga, jengkol 
leaf extract positively contains alkaloids, flavonoids, 
terpenoids, and polyphenols. Jengkol also contains lectin 
compounds.17,18
Alkaloids are antifungal derived from organic plants. In 
a research conducted by Dhamgaye, alkaloid undermines 
the integrity of the cell walls of C. albicans as well as 
interferes calcineurin pathway system. Such damage 
then causes mitochondrial dysfunction, and C. albicans 
ultimately will die.19 Lectin, on the other hand, has an 
ability to bind to hyphae and mannose. Hyphae in C. 
albicans is a structure that serves as a major tool in the 
absorption of nutrients. Therefore, impairing absorption of 
nutrients can cause disruption of spore germination of C. 
albicans. The binding of lectin - mannose that is elements 








Figure 1. Diagram of the inhibitory percentages in each treatment group against Candida albicans biofilms.
Table 3. Differences between groups based on the results of 
Mann Whitney test
Control 100mg/ml 200mg/ml 400mg/ml
Control 0.004* 0.004* 0.004*
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will trigger antibiofilm activities.9 Meanwhile, lectin and 
flavonoids have an ability to disrupt the interaction of 
cells (cell signaling pathway). The interaction of cells is a 
process of interaction between C. albicans and host cells 
that occurs in the attachment stage. The interaction stage, 
consequently, can be considered as an important stage in the 
colonization and penetration of C. albicans.9,10 Terpenoid 
has an ability to damage cell cycle system of C. albicans 
by binding proteins on the cell membrane of C. albicans, 
resulting in disruption of cell cycle leading to the death of 
C. albicans.11
In other words, jengkol leaves (Pitheecellobium jiringa) 
contain alkaloids, flavonoids, terpenoids, and lectin 
that work synergistically as antibiofilm of C. albicans, 
ultimately degrading C. albicans biofilms. The degradation 
of C. albicans biofilms is described by a decrease in the 
mean value of OD at doses of 100 mg/ ml, 200 mg/ ml, 
and 400 mg/ ml (Tabel 2). It may be concluded that the 
optimum dose of jengkol leaf extract (Pithecellobium 
jiringa) in inhibiting C. albicans bioilms is 100 mg/ ml 
with an inhibitory percentage of 83.7%.
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